Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)

Market Cap	12.18B
Revenue (ttm)	2.38B
Net Income (ttm)	560.50M
Shares Out	530.18M
EPS (ttm)	1.06
PE Ratio	21.74
Forward PE	n/a
Dividend	0.38 (1.65%)
Ex-Dividend Date	Jul 10, 2025

Volume	1,373,281
Average Volume	1,506,349
Open	22.35
Previous Close	23.01
Day's Range	22.35 - 23.04
52-Week Range	18.07 - 26.90
Beta	0.70
RSI	51.86
Earnings Date	Aug 23, 2025

About SHE:002287

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China. The company also provides plasters and ointments. Its products are used in areas of orthopedics, neurology, dermatology, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, and cerebrovascular sectors. The company was founded in 1995 and is based in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 3,170
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002287

Financial Performance

In 2024, SHE:002287's revenue was 2.34 billion, an increase of 14.32% compared to the previous year's 2.05 billion. Earnings were 582.28 million, an increase of 0.19%.